Bavarian Nordic A/S (BAVA.CO)
BAVA.CO on Copenhagen Stock Exchange
135.95DKK
16 May 2019
135.95DKK
16 May 2019
Change (% chg)
kr.-0.10 (-0.07%)
kr.-0.10 (-0.07%)
Prev Close
kr.136.05
kr.136.05
Open
kr.135.60
kr.135.60
Day's High
kr.137.15
kr.137.15
Day's Low
kr.134.10
kr.134.10
Volume
71,904
71,904
Avg. Vol
133,400
133,400
52-wk High
kr.214.80
kr.214.80
52-wk Low
kr.117.75
kr.117.75
About
Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)
Overall
| Beta: | 1.27 |
| Market Cap(Mil.): | kr.9,290.57 |
| Shares Outstanding(Mil.): | 31.98 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| BAVA.CO | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 40.08 | 29.30 | 32.55 |
| EPS (TTM): | 7.25 | -- | -- |
| ROI: | 11.17 | 14.23 | 13.82 |
| ROE: | 11.48 | 15.46 | 15.24 |
Estimates